IP Library Granted Patent US 11,939,584
Granted Patent B2
US 11,939,584 · App. 17/444,188 · Granted Mar 26, 2024

Methods and microorganisms for making 2,3-butanediol and derivatives thereof from C1 carbons

Inventors: Xinhua Zhao (Dublin, CA); Mark Anton Held (Emeryville, CA); Tina Huynh (Oakland, CA); Lily Yuin Chao (San Francisco, CA); Na Trinh (Walnut Creek, CA); Matthias Helmut Schmalisch (South San Francisco, CA); Bryan Yeh (Walnut Creek, CA); James Kealey (Sebastopol, CA); Kevin Lee Dietzel (Pacifica, CA)
Assignee: PRECIGEN, INC.
C12N15/52C12N1/20C12N9/0006C12N9/1022C12N9/88C12N15/74C12P5/023C12P7/16C12P7/18C12Y101/01304C12Y202/01006C12Y401/01004C12Y401/01005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,939,584
App. No.
17/444,188
Granted
Mar 26, 2024
Kind
B2
Abstract

Genetically modified microorganisms that have the ability to convert carbon substrates into chemical products such as 2,3-BDO are disclosed. For example, genetically modified methanotrophs that are capable of generating 2,3-BDO at high titers from a methane source are disclosed. Methods of making these genetically modified microorganisms and methods of using them are also disclosed.

Claims (21)

1. A vector comprising two or more genes encoding: (a) an acetoin reductase comprising an amino acid sequence that is at least 90% identical to SEQ ID NO: 9; (b) an alpha-acetolactate decarboxylase comprising an amino acid sequence that is at least 90% identical to SEQ ID NO: 7; and/or (c) an acetolactate synthase comprising an amino acid sequence that is at least 90% identical to any one of SEQ ID NO: 1, 3, and 19.

2. The vector of claim 1 , wherein:

(a) the acetoin reductase comprises the amino acid sequence of SEQ ID NO: 9 or a conservatively-substituted variant thereof;

(b) the alpha-acetolactate decarboxylase comprises the amino acid sequence of SEQ ID NO: 7 or a conservatively-substituted variant thereof; and/or

(c) the acetolactate synthase comprises an amino acid sequence of any one of SEQ ID NOs: 1, 3, and 19 or a conservatively-substituted variant thereof.

3. The vector of claim 1 , wherein:

(a) the acetoin reductase comprises the amino acid sequence of SEQ ID NO: 9;

(b) the alpha-acetolactate decarboxylase comprises the amino acid sequence of SEQ ID NO: 7; and/or

(c) the acetolactate synthase comprises an amino acid sequence of any one of SEQ ID NOs: 1, 3, and 19.

4. The vector of claim 1 , wherein the gene encoding the acetolactate synthase is 5′ in relation to any other gene on the vector.

5. The vector of claim 1 , wherein the gene encoding the acetoin reductase is 3′ in relation to any other gene on the vector.

6. The vector of claim 1 , wherein the gene encoding the alpha-acetolactate decarboxylase is neither 5′ or 3′ in relation to any other gene on the vector.

7. The vector of claim 1 , comprising a gene encoding an acetoin reductase.

8. The vector of claim 7 , wherein the acetoin reductase comprises an amino acid sequence that is at least 95% identical to SEQ ID NO: 9.

9. The vector of claim 1 , comprising a gene encoding an alpha-acetolactate decarboxylase.

10. The vector of claim 9 , wherein the alpha-acetolactate decarboxylase comprises an amino acid sequence that is at least 95% identical to SEQ ID NO: 7.

11. The vector of claim 1 , comprising a gene encoding an acetolactate synthase.

12. The vector of claim 11 , wherein the acetolactate synthase comprises an amino acid sequence that is at least 95% identical to any one of SEQ ID NOs: 1, 3, and 19.

13. The vector of claim 1 , further comprising a promoter that is active within a methanotroph.

14. The vector of claim 1 , wherein the vector is an integration vector.

15. The vector of claim 1 , wherein the vector is an episomal vector.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2025
From: PRECIGEN, INC.
To: BIOVERDE TECH LLC
Reel/Frame 072033/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2021
From: ZHAO, XINHUA; HELD, MARK ANTON; HUYNH, TINA; CHAO, LILY YUIN; TRINH, NA MY; SCHMALISCH, MATTHIAS HELMUT; YEH, BRYAN; KEALEY, JAMES; DIETZEL, KEVIN LEE
To: INTREXON CORPORATION
Reel/Frame 057046/0080 →
CHANGE OF NAME Recorded Aug 1, 2021
From: INTREXON CORPORATION
To: PRECIGEN, INC.
Reel/Frame 057047/0250 →
Continuity (6)
Division 16481799
Provisional Application 62588985 · Nov 21, 2017
Provisional Application 62512312 · May 30, 2017
Provisional Application 62504626 · May 11, 2017
Provisional Application 62451819 · Jan 30, 2017
Related Publication 20220049259A1 · Feb 17, 2022